For investors and research partners
the short version
The problem is easy to see. Proving the fix is the hard part.
reviresco47 LLC is a Delaware limited liability company, building under the name R47. ANCHOR is the post-discharge operating layer that keeps every hospital promise on a clock - the prescription, the referral, the follow-up - and ranks the work that closes what is still open.
The public site lays out why this year matters, why software beats hoping more navigators will scale, and how ANCHOR orders work. Sourced detail lives on The problem page; this briefing request is for material sent person to person.
What looks defensible is the maths underneath - how open promises pile up, interact, and relieve under repair - plus a worklist a coordinator can argue with. A licensed clinician decides every clinical call.
Most new clinical software stalls for want of somewhere to test. RootBound Health PLLC, R47's first BAA relationship, is a real site of care to start from. It is a data-handling contract, not an owner, parent, subsidiary or operator, and not a validator.
The company
Delaware corp
Who you would be investing in
- Legal entity
- reviresco47 LLC
- Jurisdiction
- Delaware limited liability company
- Public identity
- R47
- RootBound relationship
- First BAA relationship. Not an owner, parent, subsidiary or operator.
- Investor contact
- investors@Reviresco47.com
The thesis
narrow wedge
A narrow way into a large problem.
Healthcare records decisions well and proves follow-through badly. ANCHOR exists to make the follow-through itself visible, owned and checkable.
- Wedge
- Instrument one transitions-of-care workflow with tracked, accountable items before any prediction is switched on.
- Buyer
- Health-system clinical operations, care management, quality and safety, and enterprise technology leaders.
- Commercial path
- Paid pilot, then evidence review, then enterprise subscription with implementation support. Proposed, not signed.
- Defensibility
- Governed workflow knowledge, traceability, integration depth, permissioned evidence, and disciplined execution.
- Stage
- Foundation capabilities work internally. The production obligation layer and the models are still development gates.
- Claim boundary
- Clinical, statistical, regulatory, equity and economic performance are all unproven until the relevant gates pass.
Capital
proof, not costume
Capital turns specifications into evidence.
The raise amount stays controlled until work packages, runway, pricing assumptions and disclosures are approved. The historical planning figures below are dated inputs, not current terms.
- 01
Build
The production register, the shared core, security, observability, and readiness to integrate with hospital systems.
- 02
Prove
Endpoint adjudication, baseline comparison, independent statistics, workflow evaluation, equity analysis, external validation.
- 03
Protect
Patent scope, contributor IP controls, intended-use determination, regulatory analysis, quality-system development.
- 04
Operate
Engineering depth, clinical-safety ownership, quality and regulatory leadership, human factors, implementation continuity.
Planning baseline
its own errata
A February 2026 plan, and what is wrong with it.
Dated planning inputs. Not current terms, not a forecast, not a commitment, and not an offer to sell securities.
- Document date
- 2 February 2026
- Historical pre-seed range
- $250,000 - $500,000
- Top-line planning total
- $380,000
- Status
- Historical baseline under reconciliation. Not current offering terms.
| MVP development | $150,000 |
| Technical team | $100,000 |
| Cloud infrastructure | $25,000 |
| Legal and intellectual property | $25,000 |
| Design and user experience | $20,000 |
| Testing and quality assurance | $15,000 |
| Marketing and pitch materials | $10,000 |
| Contingency | $35,000 |
| Total | $380,000 |
Access
person to person
Ask for the briefing
The briefing covers what R47 builds in what order, how the studio plans to prove it works, what regulators are likely to say, and what each stage costs - including the detail deliberately kept off this site. Leave your details and someone will get back to you.